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Abstract 
 Borderline Personality Disorder (BPD) has been previously conceptualized as an extreme variant 
of normal personality traits, captured by continuous indices. A previous study successfully developed and 
validated a self-report BPD measure, the Minnesota Borderline Personality Disorder Scale (MBPD). I 
conducted two studies aimed at providing further validation for this measure. Results from Study 1 
(clinical sample of substance users) indicated that MBPD exhibited strong positive correlations with 
measures of convergent validity (self-report and diagnostic measures). Additionally, the MBPD showed 
similar correlations with external correlates as those of the convergent validity measures, in addition to 
incremental utility in predicting these external correlates above and beyond negative affect. Third, a 
Receiver Operating Characteristic (ROC) curve analysis indicated that diagnostic accuracy of the MBPD 
was excellent for differentiation between BPD and non-BPD individuals. Likewise, Study 2 (non-clinical 
sample of undergraduate students followed over 6 months) showed strong correlations with an index of 
convergent validity (self-report measure), similar correlations with external correlates as that of the 
convergent validity index, and incremental predictive utility. Finally, in this study, the MBPD exhibited high 
rank-order stability, but significant mean-level and individual-level change over time. These data suggests 
that these scales are measuring the same latent construct of BPD, providing further evidence for the 
construct validity of the MBPD.
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Longitudinal Validation and Diagnostic Accuracy of the MBPD 
Borderline Personality Disorder (BPD) is a personality disorder marked by severe social and 
functional impairment as well as poor long term outcomes (Skodol, et al., 2005; Whisman & Schonbrun, 
2009; Winograd, Cohen, & Chen, 2008). Characteristics of BPD include both maladaptive behvaiors and 
traits such as emotion dysregulation, outbursts of anger, impulsive and risky behaviors, self-harm, 
unstable interpersonal relationships, and disturbances in self-image (Linehan, 1993; Links, Heslegrave, 
Mitton, van Reekum & Patrick 1995; Livesley, Schroeder, & Jackson, 1992; McGue, Osler, & Christensen, 
2010; Siever & Davis, 1991; Siever, Torgersen, Gunderson, Livesley, & Kendler, 2002; Skodol et al., 
2002a; Skodol et al., 2002b). Moreover BPD is comorbid with other psychopathology including depressive 
symptoms, (Fonagy & Bateman, 2006; Perry, 1985), anxiety symptoms (Andover, Pepper, Ryabchenko, 
Orrico, & Gibb, 2005; Zanarini, et al., 1998), disordered eating (Pope & Hudson, 1989; Striegel-Moore, 
Garvin, Dohm, & Rosenheck, 1999), and both alcohol and substance abuse (Links et al., 1995; Paris, 
1997). 
Traditionally BPD has been thought of as a categorical (present or absent), “lifetime” disorder. 
However, recent research has brought three advances in the understanding of BPD. The first is that, far 
from being a life-long sentence, BPD traits and features fluctuate on both a short-term as well as long-
term level. Prior research shows that of those originally with diagnosed BPD in adulthood, only about a 
third of those met diagnostic criteria over a 1 -3 year follow-up (Paris, Brown, & Nowlis, 1987; Shea, Stout 
et al., 2002; Zanarini et al., 2003b). Likewise, Bornovalova, Hicks, Iacono, & McGue (2009) showed that 
BPD features are elevated in mid- and late adolescence, but steeply decline in young adulthood. 
The second advance is that BPD is best conceptualized as a continuous construct (Ayers, 
Haslam, Bernstein, Tryon, & Handelsman, 1999; Edens, Marcus, & Ruiz, 2008; Rothschild, Cleland, 
Haslam, & Zimmerman, 2003; Wilberg, Urnes, Friis, Pedersen, & Karterud, 1999). For instance, Edens et 
al. (2008) utilized three taxometric procedures to determine if BPD is taxonic (latent category) or 
nontaxonic (latent dimension) and found consistently that BPD showed a non-taxonic or more 
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dimensional conceptualization. And, it is now widely recognized that maladaptive personality traits are 
expressed in the general population, in the absence of any full-blown disorders, but may nevertheless 
signal a liability for a forthcoming disorder (Shiner, 2009). From this standpoint, personality disorders are 
extreme manifestations of underlying continuous dimensions (Shiner, 2009; Rothschild, Cleland, Haslam 
& Zimmerman, 2003).   
The third advance is that research indicates that BPD is best conceptualized as an extreme 
variant of normal personality features (e.g., Five-Factor Model; FFM; Clarkin, Hull, Cantor, & Sanderson, 
1993; Costa & McCrae, 1992; Saulsman & Page, 2004; Trull, Widiger, Lynam, & Costa, 2003).  For 
example, Morey & Zanarini (2000) found that the neuroticism factor of the five-factor model could 
distinguish between BPD and non-BPD individuals, and that in fact the entire FFM model accounted for a 
significant proportion of variance in BPD diagnosis for both self-report and diagnostic measures. Further, 
in three samples, undergraduate students, and two outpatient clinic samples, Trull, Widiger, Lynam, 
Costa (2003) showed that a derived expert-consensus, prototypic, FFM borderline profile was associated 
with well-validated diagnostic measures of BPD and theoretical constructs related to BPD.  
Taking into account the success of normal personality inventories in capturing abnormal 
personality disorders, a previous study used the Multidimensional Personality Questionnaire (MPQ, 
Tellegen, 1982, Patrick, Curtin, & Tellegen, 2002) to create a self-report, continuous measure of BPD, the 
Minnesota Borderline Personality Disorder Scale (MBPD; Bornovalova, Hicks, Iacono & McGue, 2011). 
The MBPD is a 19-item scale developed using items from the MPQ (MPQ; Tellegen, 1982; Patrick, 
Curtin, & Tellegen et al., 2002). Notably, the purpose of the original study was not to develop a “gold 
standard” of BPD measurement. Instead, the purpose was to capitalize on the richness of existing large 
datasets in which the MPQ – but, due to expense or participant burden, no measure of BPD was 
administered. If a valid index of BPD could be calculated from the MPQ, then the data available from 
large, longitudinal datasets (e.g., Dunedin Multidisciplinary Health Development Study) could be used to 
answer questions about BPD. 
The pragmatics behind the original development purpose notwithstanding, the MBPD showed 
excellent validity. It was significantly correlated with both diagnostic and self-report, continuous measures 
of BPD. Moreover, the MBPD provided incremental prediction of BPD symptoms over negative 
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emotionality, a construct that has considerable overlap with BPD, (Bornovalova et al., 2011; Ball, Tennen, 
Poling, Kranzler, & Rounsaville, 1997; Trull, 1992) indicating that this measure is not just indexing 
negative emotionality. Further, the MBPD predicted external correlates of BPD such as substance use 
and depression (Zanarini & Frankenburg, 1997; Zanarini et al., 1998), reinforcing that this measure 
exhibits the predicted associations between BPD traits and related external constructs, reflecting the 
functioning of the latent construct of BPD.  
Although this scale has been through a rigorous validation process, a single validation study is 
insufficient for demonstrating the validity of any measure. A follow-up validation study in independent 
samples is needed for several reasons. First, cross-validation in independent samples would show that 
the MBPD measures the same BPD traits independent of site or sample. Second, the original validation 
study lacked a test of short-term longitudinal stability. Examining the stability of a measure provides 
further evidence that the scale consistently measures BPD features at varying time points. Third, previous 
validation studies (Bornovalova et al., 2011; Rojas et al., 2013) have not examined the diagnostic utility of 
this measure (i.e. the ability of MBPD to differentiate between BPD and non-BPD individuals). Finally, 
MBPD remained a continuous measure, and to date, no study has attempted to set a diagnostic “cutoff” 
that allows for identifying individuals with BPD. 
The final point – the need for a diagnostic cutoff - stands in contrast to both my view and the 
wealth of research that indicates that BPD is best conceptualized continuously. However, there are at 
least three practical reasons to dichotomize a continuous construct. First, having a diagnostic cutoff 
allows researchers to estimate prevalence rates of BPD in large existing datasets and compare them to 
well-established population estimates. Second, multiple extant studies of BPD rely and report results 
obtained with a categorical BPD diagnosis (Gunderson et al., 2000; Zanarini, Frankenburg, Hennen, Silk, 
2003a). The ability to calculate an approximation of a BPD diagnosis allows researchers to either 
compare or replicate such studies, allowing for comparison and consistency across the BPD literature. 
Finally, a diagnostic cutoff can be used as a screening or a diagnostic tool in clinical practice settings 
where cutoffs are needed for screening, triage or billing purposes.  
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Overview of Current Investigation 
I conducted two studies that further examined the validity of MBPD. Study 1 focused on a clinical 
sample of urban substance users in residential treatment. The goals of this study were as follows. First, I 
examined the convergent validity of MBPD by testing its relationship with well-established BPD measures.  
Second, I examined that the MBPD supported the nomological network of BPD by investigating its 
relationship with external correlates that have reliably been shown to be related to the construct of BPD. 
Previous work indicated that across different measures, BPD is related to the normal personality 
dimensions of trait-impulsivity, negative affect, and distress tolerance (Links et al., 1995; Whiteside & 
Lynam, 2001; Gratz, Tull, Baruch, Bornovalova, & Lejuez, 2008; Bornovalova, Lejuez, Daughters, 
Rosenthal, & Lynch, 2005), in addition to perceived stress (Bohus et al., 2000b) a reported history of 
childhood abuse (Herman, Perry, & van der Kolk, 1989; Links, Steiner, Offord, & Eppel, 1988; Ludolph et 
al., 1990; Ogata et al., 1990; Zanarini, Gunderson, Marino, Schwartz, & Frankenburg, 1989), and 
internalizing and externalizing psychopathology (Eaton et al., 2011; James & Taylor, 2008; Miller, Flory, 
Lynam & Leukefeld, 2003). If, in fact, the MBPD measured the latent BPD construct, then the MBPD 
should be related to these variables as well. Third, I examined if the MBPD carries incremental validity 
above and beyond the negative affect, a core component of BPD (Gratz, Tull, Baruch, Bornovalova, & 
Lejuez, 2008; Bornovalova, Matusiewicz, & Rojas, 2011; Trull et al., 2008) of BPD symptoms and these 
external correlates. Fourth, I examined the MBPD in terms of diagnostic accuracy for distinguishing 
between BPD versus non-BPD individuals. Finally, I aimed to establish diagnostic cutoff points that can 
be used in prevalence estimates, as well as clinical settings. 
Study 2 focused on undergraduates followed longitudinally over a period of six months. As in 
Study 1, I examined the convergent validity, external correlates, and incremental utility of MBPD. 
Moreover, I examined the longitudinal stability of MBPD via three indices: mean-level change (or average 
change over time); rank-order stability (consistency over time in individuals’ order within the population; 
test-retest reliability); and individual-level change (individual differences in change or stability over time; 
Baltes & Nesselroade, 1973). The use of these two diverse samples allowed me to investigate the validity 
of the MBPD across populations, in turn providing support for the generalizability of the measure.  For 
detailed hypotheses please see Appendix A.  
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Study 1: Substance Users 
Participants 
Participants were 227 substance users at residential substance abuse facilities. Mean age of 
participants was 30.04 (SD = 8.40), and the sample was roughly equally split by gender (47% male, 53% 
female). Participants were 69.5% Caucasian, 13.5% African American, and 17% Hispanic. Regarding 
education, 22.4% had at least some college education, 17% completed high school or had a GED, and 
20% did not complete high school. All participants completed a battery of questionnaires, and a clinical 
interview was verbally administered. In order to measure reliability, 25% of the audio-taped interviews 
were rated independently for symptom count and diagnosis by two raters who are trained research 
assistants. If there were discrepancies in symptom ratings and/or diagnosis, consensus was reached 
through the aid of a PhD level clinician (M.B.). Participants were compensated with $20 for completion of 
the assessment. All participants were provided written consent after written and oral assurances of 
confidentiality. The study was approved by the University of South Florida Institutional Review Board. As 
there was large overlap between Study 1 and Study 2 measures, and I aimed to increase the readability 
of the manuscript, Table 1 presents a summary of study measures and reliabilities, whereas Appendix A: 
Table A1, shows the schedule of assessments, and Appendix B shows a full, detailed description of the 
measures.   
Convergent Validity 
To establish the convergent validity of the MBPD, I examined its relationship with established 
BPD measures: the PAI-BOR and the SCID-II symptom counts of BPD. Pearson correlations were used 
to test the association between MBPD and the PAI-BOR and the SCID-II BPD symptom counts.  
As seen in Table 2, the MBPD exhibited strong, positive, correlations with both the PAI-BOR (r = .70) and 
SCID-II BPD symptoms (r = .62).  
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External Correlates 
In accordance with previous studies (Bornovalova et al., 2011; Verona, Hicks, & Patrick, 2005; 
Zanarini, 2000; Zanarini & Frankenburg, 1997; Zanarini et al., 1998) and the nomological network of BPD, 
I examined the relationship between MBPD and its external correlates. First, I examined Pearson 
correlations between the MPBD and normal personality dimensions (negative and positive affect, trait 
impulsivity, externalizing traits, distress tolerance), measures of perceived and actual stressors (perceived 
stress, childhood abuse), Axis II psychopathology (conduct disorder symptoms, adult antisocial 
behaviors), Axis I psychopathology (depression, anxiety, alcohol and substance use dependence 
symptoms) and self-report alcohol use and drug use. As expected, MBPD exhibited significant 
correlations (ps<.01) with negative affect, trait impulsivity, externalizing traits, distress tolerance, 
perceived stress, and childhood trauma (Table 2). In support of its discriminant validity and consistent 
with previous research (Rojas, et al., in press; Miller, Gentile, Wilson, Pryor, & Campbell, 2010), the 
MBPD did not show significant correlations with positive affect or sensation seeking. In terms of 
psychopathology, the MBPD exhibited the expected significant correlations with both Axis I and II 
psychopathology and self-reported drug and alcohol use (rs ranged from .18 - .45 p <.01), but failed to 
correlate with substance dependence and alcohol dependence. 
Next, if the MPBD is indeed measuring the latent BPD construct, it should be correlated with the 
same external correlates as the PAI-BOR and SCID-II symptom count. And, the magnitude of its 
relationship with external correlates should be similar to the magnitude of the PAI-BOR and SCID-II 
symptoms with the external correlates. In order to investigate the latter, I performed Fisher R-Z 
transformations to test if the difference in the magnitude of the correlations were significant (p<.01). 
Results (Table 2) indicated that in almost all cases, the MBPD was related to the same external correlates 
as the PAI-BOR and the SCID-II symptoms. And, as seen in Table 2, in all cases, the magnitude of the 
relationship of MBPD with external correlates did not differ from the magnitude of the association of PAI-
BOR and SCID-II with the same external correlates. However, it is important to note that the MBPD did 
exhibit a significant correlation with past-year substance whereas the PAI-BOR did not. Additionally, the 
MBPD exhibited a significant correlation with positive urgency while the SCID-II did not. Conversely, the 
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SCID-II exhibited additional significant correlations with alcohol and substance dependence, but the 
MPBD failed to do so. 
Incremental Utility 
In order to test that the MBPD predicts these external correlate above and beyond negative affect 
– a construct that frequently overlaps with BPD, I performed a series of linear regressions that included 
the predictors of age, sex, and negative affect in Step 1, and MBPD as an additional predictor in Step 2 
predicting each external correlate individually. First and foremost, the MBPD significantly predicted BPD 
symptoms (B = .52, ΔR2 = .22, p <.01) indicating that the MBPD accounted for significant variance in BPD 
symptoms above and beyond negative affect alone. As seen in Table 3, MBPD showed incremental utility 
for normal personality variables of two indices of trait-impulsivity and distress tolerance. Next, it showed 
incremental prediction of perceived stress and history of childhood abuse. Finally, for psychopathology, 
the MBPD significantly predicted all Axis II and I psychopathology symptoms but not substance use or 
alcohol use frequency. 
Diagnostic Accuracy and Diagnostic Cutoff Points 
Finally, I examined the sensitivity and specificity of MBPD in discriminating between BPD and non 
BPD individuals, and in doing so, I established diagnostic cut-off points as well. To do so, I performed a 
Receive Operator Curve (ROC) curve analysis to investigate the area captured under the curve by the 
MBPD. The ROC analysis plots the number of individuals classified as meeting BPD diagnosis on the 
SCID-II (true positive rate or sensitivity) on the ROC curve, by the number of individuals falsely classified 
as meeting BPD diagnosis (false positive rate or 1 – specificity). Out of 227 substance users, 115 were 
classified as meeting BPD diagnosis and 111 were classified as not meeting BPD diagnosis, with 1 
missing case. A value of 0.50 indicates no discrimination or change, while a value of 1.0 indicates perfect 
discrimination between BPD individuals and on BPD individuals (Swets, 1996; Mcfall & Treat, 1999). 
Although there are no extant “hard” rules for establishing diagnostic cutoff points, the current practice is to 
set them at points which provide the maximum balance between sensitivity and specificity (van Erkel & 
Pattynama, 1998).  
 
   
 8
   
Results of the ROC analysis on the MBPD indicated an excellent level of discrimination for 
accurately distinguishing between BPD individuals and non BPD individuals, such that the area under the 
curve was .80 (95% CI: 0.74 – 0.86). As for the diagnostic cutoffs, there were two acceptable cutoff points 
(visual representation provided in Figure 1). At the cut-off score 10.77, the sensitivity was 70% and the 
specificity was 80%, resulting in type I error of 20%. This cut-off classified 70% people as true positive, 
19% as false positive, 30.4% as false negative, and 80.7% as true negative. At a more liberal estimate, a 
cutoff score of 10.09, the sensitivity was 78% and the specificity was 72%. This results in a type I error 
rate of 28%. Additionally, this cut-off classified 78% as true positive, 28.4% as false positive, 22.3% as 
false negative, and 71.6% as true negative. Previous studies suggest including both a conservative cut 
score (definite diagnosis or having the required number of symptoms to meet the diagnostic cut-off) along 
with a more liberal diagnostic cut score (probable diagnosis or meeting one less symptom than the 
diagnostic cut-off). This method included individuals who may have difficulty with reporting symptoms 
(e.g. underreporting symptoms) due to reliance on memory (Kessler et al., 2003), and those who have 
subclinical diagnoses (not meeting the threshold of DSM-IV criteria) but still exhibit significant impairment 
(Pickles et al., 2001; Kessler et al., 2003). As a conservative cut-score (definite diagnosis) often provides 
an extreme estimate, resulting in underestimation of those meeting clinical diagnosis (Elkins, King, 
McGue, & Iacono, 2006; King, et al., 2009), I included a more liberal cutscore in order to generate a more 
inclusive estimate. Thus, I created two diagnostic cutoffs: a probable cutoff (a score of 10) and a more 
conservative, cutoff (a score of 11). Notably, as scores on the MBPD are integers, integer cutoff values 
were used. 
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 Table 1.  
Assessment Measures 
Variable Instrument Description Received In: Reliability 
Target 
Measure 
MBPD (Bornovalova, Hicks, 
Patrick, Iacono, & McGue, 
2011) 
Putative indicator of BPD 
traits 
Study 1 and 
Study 2  
s = .76 - .77 
 Convergent     
Self-report Personality Assessment 
Inventory (PAI-BOR; Morey, 
1991) 
Self-report continuous 
measure of BPD traits 
Study 1 and 
Study 2  
s = .86 -.72 
Diagnostic SCID-II for BPD (Structured 
Clinical Interview for DSM-
IV Axis II Disorders; First, 
Gibbon, Spitzer, Williams & 
Benjamin, 1997) 
BPD symptom count from 
diagnostic interview 
Study 1   = .74 
External Correlates - Personality and 
Trauma History 
   
Negative and 
Positive 
Affect 
Positive and Negative Affect 
(PANAS; Watson & Clark, 
1988) 
Self-report measure of 
state negative and 
positive affect 
Study 1 and 
Study 2  
s = .72 - .85 
Trait 
Impulsivity 
UPPS-P Impulsive Behavior 
Scale (UPPS-P; Lynam, 
Smith, Whiteside, & Cyders, 
2006) 
Negative urgency, (lack 
of) premeditation, 
perseverance, sensation-
seeking, positive urgency,  
scales of UPPS 
s = .82 - .90 
EXT 
inventory 
Externalizing Behaviors 
(EXT-159; Venables, 
Patrick, 2012). 
Externalizing traits and 
behaviors  
s = .74 - .92 
Distress 
Tolerance 
Frustration Discomfort 
Scale (FDS Harrington, 
2005) 
Distress Tolerance Scale 
(Simons & Gaher, 2005) 
Tolerance of Negative 
Affective States (TNASS - 
Bernstein and Brantz, 2012) 
Self-report measures of 
individual’s tolerance of 
psychological distress 
Study 1   = .99 
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Table 1 continued 
Perceived 
Stress 
Perceived Stress Scale 
(PSS – Cohen & 
Williamson, 1988) 
Self-report of stress in 
daily life over the last 
month  
Study 1 and 
Study 2 
 
s .86–.96  
Factor loadings 
>|.5||  
 
Childhood 
Abuse 
Childhood Trauma 
Questionnaire (CTQ; 
Bernstein et al., 2003) 
Childhood sexual, 
physical, emotional abuse 
 
External Correlates – Psychopathology    
CD SCID-II for Antisocial 
Personality Disorder 
(Structured Clinical 
Interview for DSM-IV Axis II 
Disorders; First, Gibbon, 
Spitzer, Williams & 
Benjamin, 1997) 
Symptom counts for 
conduct disorder   
Study 1  
 =.96 
AAB Symptom count of adult 
antisocial behaviors  
 = .67 
 
Depression 
Mini International 
Neuropsychiatric Interview 
(M.I.N.I.; Sheehan, Janavs, 
Baker, & Harnett-Sheehan, 
1999) 
Symptom counts of 
lifetime and current major 
depressive disorder  
Study 1 and 
Study 2  
s = .79 – 1.00 
Anxiety  Composite of symptom 
counts for lifetime panic 
disorder, current post-
traumatic stress disorder, 
current generalized 
anxiety disorder 
s .74-1.00 
 
Alcohol 
Dependence 
Symptom count for 
current alcohol 
dependence 
s = 1.00 -1.00 
Substance 
Dependence 
Maximum endorsed 
symptoms across 
amphetamines, cannabis, 
cocaine, hallucinogens, 
inhalants, opioids, PCP, 
and sedatives 
s = .96 -1.00 
 
Alcohol Use National College Health 
Risk Behavior Survey 
(NCHRBS; Center for 
Disease Control, 1997) 
Past year alcohol use Study 1 and 
Study 2  
—2 
Substance 
Use 
Past year substance 
abuse  
—2 
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Table 1 continued 
Note: Diagnostic reliability was calculated using the kappa coefficient (), scale internal consistency was 
evaluated using Cronbach’s alpha (),composite measure was calculated utilizing a principals component 
analysis (PCA), the reliability of a composite measure composed of multiple measures was computed 
separately for each measure (Cronbach’s alpha). The alpha could not be computed because of the small 
number of items (three or less). Study 1 refers to substance users; Study 2 refers to college students. 
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Table 2. 
Substance Users Correlations between Convergent Validity Measures and External 
Correlates 
 MBPD PAI-BOR 
BPD 
Symptoms 
MBPD-PAI 
Contrast Z 
MBPD-BPD 
Contrast Z 
MBPD ----------- .70** ------------ ------------ ----------- 
PAI-BOR ----------- ----------- .61** 1.51 ------------ 
BPD Sx 
 .62** ----------- ------------ -------------- ------------ 
PANAS-PA -.03 -.01 -.07 -.29 .40 
PANAS-NA .40** .49** .37** -1.16 .37 
Positive 
Urgency .27** .34** .16 -.82 1.07 
Negative 
Urgency .34** .50** .30** -1.89 .49 
Lack of 
Perseverance .24* .39** .29** -1.61 -.47 
Lack of 
Premeditation .20* .41** .24* -2.26 -.37 
Sensation 
Seeking .00 .08 .02 -.77 -.14 
EXT  .45** .50** .39** .-.67 .76 
Distress 
Tolerance -.42** -.51** -.46** 1.13 .43 
Childhood 
Abuse .31** .33** .36** -.22 -.54 
Perceived 
Stress .41** .56** .39** -2.02 .25 
Conduct 
Disorder Sx .32** .18** .23** 1.50 1.01 
Adult Antisocial 
Behavior Sx .45** .46** .50** -.12 -.68 
Anxiety Sx 
 .56** .52** .60** .65 -.63 
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Table 2 continued 
Major 
Depressive Sx  .39** .40** .56** -.05 -2.25 
Alcohol 
Dependence 
Sx .16 .17 .20* -.05 -.44 
Substance 
Dependence 
Sx .13 .11 .30** .22 -1.89 
Past-year 
Alcohol Use .21** .24** .17** -.31 .40 
Past-year 
Substance Use .25** .18 .20* .76 .54 
Note. *p<.01, **p<.001. MBPD-PAI/MBPD-BPD contrast Z indicate difference in magnitude between 
correlations between MBPD and external correlates compared to convergent validity measures and 
external correlates. Negative contrast z indicates that the correlations for the convergent validity 
measures (PAI-BOR/SCID-II BPD symptoms) are higher. Sx = symptoms 
.
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Table 3.  
Predictive Utility of MBPD of External Correlates in Substance Users. 
 Step 1 Step 2 
 Age Sex NA 
Multiple 
R R2 Δ Age Sex NA MBPD 
Multiple 
R R2 Δ 
BPD Sx .-.08** -.26** .32** .45 .20** .01 -.21** .13 .52** .65 .22** 
Positive 
Urgency -.10 .08 .12 .17 .03 -.05 .11 .02 .27* .30 .06* 
Negative 
Urgency -.08 -.03 .19 .21 .04 -.03 -.01 .07 .30** .34 .07** 
Lack of 
Premeditation -.11 -.25* .19* .35 .12** -.09 -.24* .16 .10 .36 .01 
Lack of 
Perseverance .00 -.11 .33** .36 .13** .02 -.10 .28** .13 .38 .01 
Sensation 
Seeking -.17 .09 -.06 .22 .05* .16 .10 -.07 .03 .22 .00 
EXT inventory -.15 
.
06 .27** .31 .10** -.09 .11 .13 .40** .47 .13** 
Distress 
Tolerance .08 .05 -.34** .35 .12** .03 .02 -.22* -.33** .47 .09** 
Perceived 
Stress -.18* -.11 .44** .50 .25** -.14 -.09 .35** .23* .54 .04* 
Childhood 
Abuse .14 -.25** .03 .31 .10** .19* -.23* -.08 .29** .41 .07** 
Conduct 
Disorder Sx -.20* .18 .05 .29 .08* -.14 .21* -.08 .36** .43 .11** 
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Table 3 continued 
Adult Antisocial 
Behaviors -.01 -.07 .19 .24 .06* -.01 -.07 .04 .40** .43 .13** 
Major 
Depressive 
Disorder Sx .05 -.24* .29** .42 .17** .10 -.21* .17 .30** .50 .07** 
Anxiety .07 -.12 .45** .49 .24** .15 -.07 .27** .46** .64 .17** 
Alcohol 
Dependence Sx .04 -.03 .07 .09 .01 .07 -.01 -.01 .20 .20 .03 
Substance 
Dependence Sx .02 -.15 .15 .24 .06 .02 -.15 .14 .04 .24 .00 
Past-Year 
Alcohol Use .05 .05 .12 .13 .02 .08 .07 .04 .21 .22 .03 
Past-Year 
Substance Use -.18 -.05 .12 .22 .05 -.14 -.03 .04 .20 .28 .03 
Note. * p<.01, **p<.001.Standardized regression weights are presented. Age, sex, and negative affect entered at Step 1, MBPD added at Step 2. 
Sx = symptoms 
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Figure 1. Substance Users ROC Curve  
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Study 2: Undergraduate Students 
Participants 
Participants were 348 University of South Florida undergraduates recruited from the SONA 
subject pool of Psychology students. Approximately half of these students (N = 233) were followed 
longitudinally across three time points, termed Assessment 1 (A1), A2 (M = 91.64 days later, SD = 64.85) 
and A3 (M =91.67 days after A2, SD = 61.22). Mean age was 20.47 (SD = 4.30) with 25% males, 75% 
females. The ethnicity breakdown was, 52% Caucasian, 16% African-American, 20% Hispanic/Latino, 
11% Asian/Southeast Asian, and 1% Native American.  The follow up rate was 88% at A2 and 79% at A3. 
All participants completed a battery of questionnaires, and a clinical interview was verbally administered. 
All procedures were identical at each assessment time point, and the clinical interview reliability 
procedure was identical to that used with the substance user sample. Participants received $20 for 
completion of each study visit. All participants were provided written consent after written and oral 
assurances of confidentiality. The study was approved by the University of South Florida Institutional 
Review Board. Table 1 presents a summary of study measures and reliabilities. 
Convergent Validity and External Correlates 
Similar to the results among substance users, MBPD exhibited strong, positive, correlations with 
the convergent validity measure, the PAI-BOR (Table 4).  
Next, as seen in Table 4, the MBPD exhibited significant correlations with the normal personality 
dimensions of most indices of impulsivity, negative affect, and distress tolerance as well as with perceived 
stress but not history of childhood abuse. In contrast to the results with substance users, the MBPD was 
not significantly related to lack of premeditation or childhood abuse. In support of its discriminant validity, 
the MBPD did not correlate with sensation seeking or positive affect – a result consistent with the results 
among substance users and previous work (Rojas et al., 2013; Miller et al., 2010). With regards to 
psychopathology, the MBPD exhibited significant correlations with anxiety symptoms, MDD, and self-
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report past year substance use (rs = .15 – 53, p<.01), with the exception of the relationship with past-year 
substance use, which was again similar to that of Study 1.  
As in Study 1, I examined a) if MBPD is correlated with the same external correlates as the PAI-
BOR, and b) if the magnitude of its relationship with external correlates is similar to the magnitude of the 
PAI-BOR external correlates. Results (Table 4) indicated that that in almost every case, the MBPD was 
related to the same external correlates as the PAI-BOR. And, comparisons of the magnitude of 
associations indicated no significant differences. It is important to note, that the PAI-BOR did exhibit an 
additional significant relationship with childhood abuse, while MBPD failed to exhibit this relationship. This 
indicated that the MBPD and PAI-BOR show virtually the same magnitude of relationship with external 
correlates.  
Incremental Utility 
Next, I examined if the MBPD predicts external correlates above and beyond negative 
emotionality. As in Study 1, for each external correlate, I fit two regression models, in Step 1, I entered 
age, sex, and negative affect, and in Step 2, I entered MBPD. Results (Table 5) indicated that, even after 
accounting for negative affect, MBPD significantly predicted indices of impulsivity, distress tolerance, 
perceived stress, and a history of childhood abuse. Next, MBPD predicted anxiety symptoms, and MDD 
symptoms, but neither alcohol nor substance use disorders or frequency of use. Overall, these results 
indicated that the MBPD is in fact predicting correlates of BPD above and beyond a construct that highly 
overlaps with BPD, supporting its incremental utility.  
Rank-Order Stability 
Next, I assessed rank-order stability, or the extent to which participants’ MBPD scores remained 
stable, relative to that of their peers, by conducting a series of Pearson correlations between A1, A2, and 
A3. MBPD exhibited high rank-order stability across the three assessment points for the entire sample 
(A1 – A2: r = .67, p<.001; A2 – A3: r = .72 p<.001; A1 – A3: r = .72, p<.001). These results support that 
MBPD was relatively stable over time and indicated that individuals who are relatively high at A1 are also 
in the top ranges for A2 and A3.  
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Mean Level Change  
Before proceeding to the longitudinal analyses, I noted that participants had considerable 
variability for number of days between assessments. The average number of days between A1 and A2 
was 91.64 days (SD = 64.85, Range = 343 days), and between A2 and A3 was 91.67 days (SD = 61.22; 
Range = 377). Thus, I regressed the variability in time between A1 and A2 (the mean number of days 
between assessment and the squared term of mean number of days between assessments) from MBPD 
scores at A2, and the variability in time between A2 and A3 from MBPD scores at A3.  
Mean-level change refers to the magnitude of change in the average scores over time for a given 
population. A repeated measures ANOVA with time as the within-level factor, and sex as the between-
level factor was used to determine if there was mean-level change in MBPD over three assessment time 
points, and if change in MBPD scores differed by sex. In addition, univariate ANOVAs were run to identify 
any gender differences in mean-level MBPD scores at each assessment. Results (Figure 2) indicated that 
across assessments, there was a moderate and significant effect of time [F(2) = 14.80, p <.001, d = .58]. 
However, upon further investigation, these effects were found to be significant specifically between A1 
and A2 [F(1) = 16.34, p <.001, d = .57], and A1 and A3 [F(1) = 20.10, p <.001, d = .67], such that there 
were large effects of time. When examining the magnitude of change between A2 and A3, there was no 
effect of time [F(1) = .40, p = .529, d = .09]. These results suggested that significant mean-level change 
occurred between A1 and A2. Further, there was no effect of sex overall [F(1) = .01, p = .930, d = .00] or 
at any specific time point (All Fs < .01; all ps = ns, all ds < .07). There was no gender by time interaction 
[F(1) = 1.21, p = .272, d = .17].  
Individual Level Change 
Finally, I investigated individual level change in MBPD scores over time using an individual 
growth curve modeling approach. This allowed me to account for the nestedness of the data such that 
assessments were nested within individuals. I fit several individual growth curve models using PROC 
MIXED in SAS with the Maximum Likelihood (ML) estimator that included both fixed and random effects. 
The fixed effects provide mean parameter values for the sample, and the random effects refer to the 
variability of the parameters estimates from the individual participants. Significant random effects indicate 
that there are interindividual (between individuals) differences in intradindividual (within individuals) 
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change over time. The first model, termed the ‘Unconditional Growth Model’, included a random effect of 
the intercept. This model allows us to estimate the intraclass correlation (ICC) accounting for between 
individual and within individual variance (Raudenbush & Bryk, 2002). The second model termed ‘Linear 
Growth Model’ included time as a fixed and random effect. I compared model fit utilizing the 2 x Log 
Likelihood (-2LL) ratio test to choose the more parsimonious model. The third model termed ‘Quadratic 
Growth Model’ included fixed effects of the squared term of time and sex as additional predictors of 
change over time. The quadratic term was included as a fixed effect only, because due to the small 
degrees of freedom, estimating the variance of all parameters (intercept, slope, quadratic) may result in 
finding significant results simply due to chance, thus increasing the Type I error. 
Please refer to Table 6 for model fit estimates. The unconditional growth model showed that the 
ICC = .65, indicating that 65% of the total variance in MBPD scores were accounted for by between 
individual variance, however the remaining 35% was within individual variance. Therefore, it was 
appropriate to use a multilevel modeling approach to estimate this within individual variance. First, I 
compared change in model fit from the baseline model to the linear growth model using the -2LL 
likelihood ratio test, Δχ2 (3) = 23.90, p <.001 and chose the latter as it showed significantly better fit. 
Results for the linear growth model showed that on average (β00) individuals scores were 7.41 at A1 or 
baseline. In addition, there was considerable variance around the intercept, τ00 = 10.91, meaning that at 
baseline some individuals had higher scores while others had lower scores such that roughly 95% of 
score fell between .80 – 14.01. Further, on average, individuals’ scores decreased by .0049 per day (β10), 
thus over 90 days scores decreased by .44 at A2, and over 180 days, scores decreased by .88 at A3. 
These results indicated a small effect of time on the negative slope or growth rate of individuals [t(384) = -
4.03, d = -.41, p<.001]. Moreover, there was a modest amount of variance in this growth rate (slope) τ11= 
.000069, suggesting that some individuals MBPD scores change at a faster rate than others, where 95% 
of the range in growth rates fell between .02 -.02. Finally, negative covariance of the intercept and slope 
suggested that those with higher scores change at a slower rate, z = -2.27, p <.05. The final model, the 
quadratic growth model, with sex as an additional predictor showed significantly better fit than the linear 
growth model using the -2LL likelihood ratio test, Δχ2 (1) = 9.20, p <.01, supporting that the addition of 
the quadratic term improved model fit. Therefore, the effect of the quadratic term served to bend the 
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curve of the linear trend, indicating that the rate of decline in MBPD scores starts to decrease over time, 
β20 = .00003, supporting quadratic or nonlinear change over time. However, the addition of sex as a 
predictor was not significant. Thus these results indicated that there was a significant effect of time on 
change in individual’s scores, and that there was significant variability in this change at the individual 
level. Additionally, on average, there was a small yet significant decrease in the rate of decline of change 
in MBPD scores over time. Taken together these results suggested there were relatively small 
interindividual differences in intraindividual change in scores over time.   
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Table 4. 
Undergraduate Students Correlations between Convergent Validity Measures and External Correlates 
 MBPD PAI MBPD-PAI Contrast Z 
MBPD ------------ .73** ------------ 
PAI-BOR ------------ ------------- ------------ 
PANAS-PA -.12 -.20** .85 
PANAS-NA .29** .34** -.51 
Positive Urgency .35** .35** .03 
Negative Urgency .53** .63** -1.43 
Lack of Perseverance .24** .39** -1.64 
Lack of Premeditation .11 .16 -.54 
Sensation Seeking .10 -.06 1.57 
Distress Tolerance -.41** -.47** .39 
Perceived Stress .52** .61** -1.40 
Childhood Abuse .17 .29** -1.29 
Anxiety Sx .33** .43** -1.55 
Major Depressive Sx .40** .46** -1.09 
Alcohol Dependence Sx .07 .10 -.41 
Substance Dependence Sx  .09 .11 -.32 
Past-year Alcohol Use -.01 .04 -.61 
Past-year Substance Use .15* .17* -.34 
Note*p<.01, **p<.001. MBPD = Minnesota Borderline Personality Disorder Scale and PAI-BOR = 
Personality Assessment Inventory – Borderline Scale. MBPD-PAI indicate differences in magnitude 
between correlations between MBPD and external correlates compared to PAI-BOR with external 
correlates. Negative signs for “Measure Difference Contrast Z” indicate that the correlation between PAI-
BOR and external correlates is higher. Sx = Symptoms 
.
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Table 5. 
 
      
Predictive Utility of the MBPD in Undergraduate Students 
 Step 1 Step 2 
 Age Sex NA 
Multiple 
R R2 Δ   Age Sex NA MBPD 
Multiple 
R R2 Δ   
Positive 
Urgency -.07 
.25*
* .27** .35 .12** -.02 .25** .18* .30** .45 .08** 
Negative 
Urgency -.05 .05 .26** .26 .07* .02 .04 .11 .51** .55** .23* 
Lack of 
Premeditation -.05 .06 .07 .10 .01 -.04 .06 .05 .09 .13 .01 
Lack of 
Perseverance -.02 .07 .26** .26 .07* .01 .06 .21* .18 .31 .03 
Sensation 
Seeking -.08 
.28*
* .02 .29 .08* -.07 .27** -.01 .10 .30 .01 
Distress 
Tolerance -.01 .16 -.31** .37 .14** -.06 .16* 
-
.21* -.35** .49 .11** 
Perceived 
Stress -.08 -.13 .42** .46 .21** -.02 -.14 
.31*
* .39** .59 .13** 
Childhood 
Abuse .20* .03 .04 .20 .04 .23* .02 -.03 .22* .28 .04* 
Major 
Depressive 
Disorder .19* -.02 .22* .29 .08* .23** -.03 .13 .34** .43 .10** 
Anxiety 
Symptoms .20* -.13 .32** .41 .17** .24** -.14 
.24*
* .28** .49 .07** 
Alcohol 
Dependence .03 .23* .06 .23 .05 .04 .23* .04 .08 .24 .01 
Drug 
Dependence -.04 .07 .01 .08 .01 -.03 .07 -.01 .09 .12 .01 
Past-year 
Alcohol Use .21* .18 .03 .27 .07* .22* .18 -.01 .10 .28 .01 
Past-year 
Drug Use -.06 .21* .01 .22 .05 -.04 .20* -.03 .16 .26 .02 
Note. * p<.01, **p<.001.Standardized regression weights are presented. Age, sex, and negative affect entered 
at Step 1, MBPD added at Step 2. Sx = symptoms 
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Figure 2. Mean Level Change. Effect sizes (Cohen’s d) above each assessment time point test for gender 
differences and significance levels for these differences at each assessment. There were no gender 
differences at any time point. 
.  
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Table 6.  
Individual Growth Curve Model Estimates 
 Unconditional Growth Linear Growth 
Quadratic Growth by 
Sex 
Fixed Effects    
Intercept 
β00 (SE) 
7.05 (.22)*** 
t(231) = 31.90*** 
7.41 (.25)*** 
t(231) = 30.00*** 
7.53 (.28) 
t(230) = 26.43*** 
Slope 
β10 (SE)  
-.0049 (.0012) 
t(384) = -4.03*** 
-.012 (.002) 
t(383) = -4.52*** 
Sex 
Β30 (SE)   
.13 (.49) 
t(230) = .27 
Acceleration Rate  
β20 (SE)   
.00003 (.00001) 
t(383) = 3.05** 
Random Effects    
Variance of intercept 
τ00 (SE) 9.29 (1.07)*** 10.91(1.36)*** 10.90 (1.35)*** 
Variance of slope  
τ11 (SE)  .000069 (.000031)* .000061(.000030)* 
Covariance of intercept 
and slope  
τ10 (SE)  -.01 (.01)* -.01 (.01)* 
Residual Variance  
σ (SE) 4.97 (.36)*** 4.14 (.37)*** 4.08 (.36)*** 
-2LL 3148.10 3124.20 3115.00 
df 3 6 8 
*p<.05, **p<.01, ***p<.001. The unconditional growth model included a random intercept only. The linear 
growth model included a random intercept and slope of time. The quadratic growth model included a fixed 
effect of time squared and an additional predictor of sex. Some parameter estimates are carried out 
further than two decimal places to indicate actual value. -2LL = -2 Log Likelihood. df= degrees of 
freedom. 
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Discussion 
I conducted two studies that aimed to further validate the MBPD. Overall the general expectations 
regarding the construct validity of the MBPD were supported. Across both samples, the MBPD showed 
strong, significant correlations with gold standard measures of BPD (self-report measure PAI-BOR and 
diagnostic measure SCID-II BPD). Next, across both samples, the MBPD showed correlations with 
normal personality dimensions, perceived stress, trauma, and Axis II and I psychopathology that have 
been shown to be related to the BPD construct in previous studies and are part of the construct’s 
nomological network (Goldman, Dangelo, & Demaso, 1993; Trull et al., 2001; Zanarini, Frankenburg, 
Hennen, & Silk, 2003). These results support that in fact the MBPD is behaving as the latent construct of 
BPD is expected to act. Third, in both studies, the MBPD was related to the same external correlates as 
the PAI-BOR and the diagnostic BPD symptom count. Further, the magnitude of the relationships 
between the MBPD and external correlates were similar to the relationships between the gold standard 
measures and external correlates, showing that the MBPD is behaving much like the gold standard 
measures. However, there were a few external correlates that the MBPD did not exhibit significant 
correlations with but the other convergent validity measures did, and this could be due to measurement 
variance or results found by chance. For example, alcohol dependence was related to SCID-II BPD 
symptoms but not the PAI-BOR or MBPD, suggesting that it could be the nature of the measure rather 
than actual differences in relationships between these measures and external correlates. Both these 
measures were diagnostic, clinician administered interviews (SCID-II BPD, SCID-I for Alcohol 
Dependence) while the PAI-BOR was a self-report continuous measure. Further due to the multiple 
amount of tests performed, some differences may be due to Type I error or chance. Fourth, the MBPD 
significantly predicted several external correlates above and beyond negative affect, indicating once 
again that MBPD is not just measuring affective distress. Moreover, these results were similar across 
samples. Taken together, these results provide further support for the validity of the MBPD in both clinical 
and non-clinical samples.  
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Beyond the usual construct validity indices, I have made three additional contributions regarding 
the validity of this measure. First, I provided novel evidence that the MBPD displays excellent 
discrimination in terms of identifying between BPD and non BPD individuals, as illustrated by the ROC 
analyses. A previous study reported that that the PAI-BOR exhibits a reasonable or good level of 
discrimination for accurately distinguishing between BPD individuals versus non-BPD individuals (Distel, 
Hottenga, Trull, & Bornovalova, 2008), and the data indicate that the MBPD is performing as well as the 
PAI-BOR. Next, I established “probable” and “definite” cutoff scores on the MBPD for the use in research 
and clinical settings. As I noted in the introduction, cutoff scores allow for comparison of prevalence rates 
to large epidemiological or clinical studies; comparison of results obtained with the MBPD to studies that 
use the traditional diagnostic cutoff; and allows for screening, triage or billing purposes in clinical settings.  
This study utilized one statistical approach to produce cut-scores; however it is important that 
future studies validate these cut scores using other methodical approaches in multiple samples. For 
example, one approach would be exploring Item Response Theory (IRT) based methods for choosing cut 
scores (see Emons, Sjitsma, & Meijer, 2007; Hendrawan, Glas, & Meijer 2005) including those that take 
into account the multidimensionality of a measure (see Reckase, 1997). Thus this could provide further 
evidence that in fact the cut scores presented here show the same discriminatory ability in other samples.  
Finally, I examined the short-term longitudinal stability and change of the MBPD. MBPD exhibited 
high test-retest reliability or rank-order stability, indicating that individuals who scored the highest relative 
to their peers on the MBPD at baseline, will remain near the top six months later. Another study that 
looked at test-retest reliability of the PAI-BOR over the same time period, indicated similar rank order 
stability (Trull et al., 1995). However, on a mean-level, the MBPD exhibited significant change over time, 
showing moderate effects of time specifically between A1 and A2. Finally, there was small but significant 
individual-level change meaning that individuals are changing at different rates, and thus average change 
over time does not represent the entire sample. Moreover, this individual rate of change is not linear such 
that rate of decline in scores slows over time. This individual level variability supported the construct 
validity of this measure across time as evidenced by prior researchers. Previous research suggests that 
BPD traits fluctuate over time (Schmideberg, 1959, Hopwood et al., 2009; Morey & Hopwood, 2012), and 
that these individuals demonstrate similar intraindividual change as shown in the current study (Hopwood, 
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Thomas, Markon, Wright, & Krueger, 2012). Overall, it appears that, across studies, the MBPD is 
accurately measuring the latent construct of BPD.  
There are several strengths to this study. First, I investigated the construct validity of the MBPD in 
two fairly large samples, including clinical and non –clinical samples. Second, the samples were fairly 
diverse and representative of the general ethnic break-down of the population. Third, one of the samples 
was followed longitudinally, allowing for examination of test-retest reliability (also rank-order stability). 
However, several limitations for this study should be noted. First, there was a gender imbalance among 
the undergraduate students, such that there were nearly four times as many females in comparison to 
males. It is possible that this imbalance may have skewed the results more in the direction of the females. 
Although gender differences were not the main focus of this paper, it is important that future research 
replicate the current work while balancing the gender breakdown, specifically in a non-clinical sample. 
Secondly, the undergraduate sample lacked an additional diagnostic measure of convergent validity 
which would have added to the construct validity and diagnostic ability of the MBPD in a non-clinical 
sample.  
In general, further validation of a short, self-report measure of BPD traits has several advantages. 
For example, archival data sets, or other longitudinal, epidemiological samples that include other 
psychopathology and personality measures like the Multidimensional Personality Questionnaire, but no 
direct assessment of BPD traits would benefit from this measure, as it would allow these researchers to 
easily derive the MBPD from the MPQ (e.g., Dunedin Multidisciplinary Health Development Study, Caspi, 
et al., 1997; Iowa Youth and Families Project, Iowa Single Parent Project; Donnellan, Assad, Robins, & 
Conger, 2007; Donnellan, Conger, & Burzette, 2007; Ge & Conger, 1999; Kim, Conger, Lorenz, & Elder, 
2001; the Minnesota Study of Twin Reared Apart, Bouchard, Lykken, McGue, Segal, & Tellegen, 1990; 
and the Minnesota Twin and Family Study, Iacono, Carlson, Taylor, Elkins, & McGue, 1999).  
These and other datasets that include the MPQ can then provide information about BPD that was 
previously unavailable. For instance, the calculation of BPD features in these datasets will allow us to 
understand the etiological principals, underlying vulnerabilities, longitudinal course, and psychophysiology 
of the disorder. In turn, this may lead to a better understanding of prevention, and treatment of this form of 
psychopathology.  
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Appendix A. Hypotheses 
1. Convergent validity: MBPD scores would show strong, positive correlations with both the 
BPD diagnostic measure and self-report measure of BPD.   
2. External correlates:  
a. In accordance with previously established correlates of BPD, the MBPD would 
demonstrate a significant, moderate, positive correlation with external correlates such as 
childhood trauma, Axis I Psychopathology (e.g. Post Traumatic Stress Disorder, PTSD), 
distress tolerance,  impulsivity,  and risky behaviors (e.g. substance use, alcohol use), 
and  antisocial, or externalizing behaviors. 
b. In addition,  the MBPD should wield predictive, incremental utility of these external 
correlates, such that it uniquely predicts these correlates above and beyond negative 
affect, a core component of BPD, and therefore a construct that frequently overlaps with 
BPD (Bornovalova et al., 2011a; Bornovalova, Matusiewicz, & Rojas, 2011b; Gratz, Tull, 
Baruch, Bornovalova, & Lejuez, 2008;; Trull, Solhan,Tragesser, et al., 2008;; Selby, 
Anestis, Bender, 2009; Glenn & Klonsky, 2009) . 
3. Test-retest reliability/Rank Order Stability.  The MBPD would exhibit longitudinal stability at 
three time points, such that the correlation between administrations at baseline, 7 weeks, and 
14 weeks should be strong, positive correlations.  
4. Diagnostic Accuracy: 
a. The MBPD will yield good discriminant ability for distinguishing between BPD and non 
BPD individuals. This ability will be the similar to the discriminatory ability of the PAI-BOR 
for distinguishing between BPD and non-BPD individuals (Bell-Pringle, Pate, & Brown, 
1997; Kurtz & Morey, 2001; Morey, 1991, 1996) 
5. Mean Level Change/Individual Level Change: 
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Appendix A. Continued 
a. Given the mixed literature surrounding the stability of BPD traits over time, I did not have 
hypotheses regarding the how these traits function over time. Studies suggest that BPD 
traits decline over time, especially during young adulthood, e.g. ages 17 - 24 
(Bornovalova et al, 2009); similarly, a study of the short-term diagnostic stability of BPD 
showed that over 6 months, there was a significant decline in number of criteria met 
(Shea et al., 2002). However other studies suggest that BPD is a chronic personality 
disorder (e.g. DSM-IV for BPD), and should be consistent over time. Hence, I had no 
strict hypotheses regarding the stability or change in BPD traits over time.  
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Appendix B. Schedule of Assessments 
 
 
 
 
Table B1.  
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Appendix C. Full Description of Measures 
 
Target measure for validation 
 Minnesota Borderline Personality Disorder Scale (MBPD; Bornovalova, Hicks, Patrick, Iacono, & 
McGue, 2011). The MBPD is a 19-item scale developed using items from the Multidimensional 
Personality Questionnaire (MPQ; Tellegen, 1982), a well-validated omnibus measure of normal 
personality. Previous work indicates that dimensional measures of BPD such as the Personality 
Assessment Inventory-Borderline scale (PAI-BOR; Morey, 1991), the Inventory for Interpersonal 
Problems-BPD scale (IIP-BPD; Lejuez et al., 2003; Pilkonis, Yookung, Proietti, & Barkham, 1996), and 
DSM-IV based BPD diagnostic interviews strongly correlated with the MBPD (r’s = .80-.89 with PAI-BOR 
and estimated PAI-BOR; r’s = .60-.66 with DSM-IV diagnostics; r’s = .60 with IIP-BPD) across normative 
and clinical samples (Bornovalova et al., 2011; Bornovalova et al., 2012; Rojas et al., in press). 
Additionally, in a sample of young female twins, MBPD scores demonstrated similar heritability as 
estimated PAI-BOR scores and a DSM-IV interview based diagnostic screener (Rojas et al., in press). 
Finally, consistent with the nomological network that of  BPD, MBPD scores exhibited medium to large 
correlations with known BPD correlates including negative affect, impulsivity, antisocial behaviors, 
interpersonal problems, eating disorders, anxiety disorders, major depressive disorder, and alcohol and 
drug use (Bornovalova et al., 2011; Bornovalova et al., 2012; Rojas et al., in press). In both samples, 
internal consistency, Cronbach’s α (alpha) was good; substance users (α = .77) and undergraduate 
students (Cronbach’s α = .76, α =.74, α = .70 for all three assessments respectively) . 
Measures of convergent validity 
In both studies (substance users and undergraduate students) the continuous, self-report index of 
BPD was the Personality Assessment Inventory Borderline Features Scale (PAI-BOR; Morey, 1991). The 
PAI-BOR assesses severe personality pathology that is related to BPD and personality disorders. It 
consists of 24 items that are rated on a 4-point scale, and the possible total ranges from (0 –3; false, 
slightly true, mainly true, very true).  
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Appendix C. Continued 
This scale taps four empirically derived dimensions for borderline phenomenology: affective instability, 
identity problems, negative relationships, and self-harm (Grinker, Werble, & Drye, 1968; Morey, 1988). 
Multigroup confirmatory factor analysis showed that the PAI-BOR is measurement invariant across sex 
and age (De Moor, et al., 2009). The PAI-BOR has good internal consistency (α = .84; Bornovalova, et 
al., 2011; Morey, 1991), high test-retest reliability over a 3-4 week time period (r = .86, Morey, 1991 
(Morey, 1991) and good convergent and discriminant validity (Stein, et al., 2007; Trull, 1995). Reliability in 
the current samples was as follows. In both samples; substance users and undergraduate students, 
Cronbach’s α = .86 and α= .72 respectively. 
Only study 1 (substance users) received the diagnostic measure of BPD. Specifically, the 
diagnostic measure was the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II) to 
determine BPD diagnosis as well as symptom count (First, Gibbon, Spitzer, Williams, & Benjamin, 1997). 
The interviews were given prior to administration of the self-report measures so there is no prior 
knowledge of scores on other self-report measures on the part of the interviewer. Interviews were 
conducted by trained graduate students or trained research assistants. In order to measure reliability, 
25% of the audio-taped interviews were independently for symptom count and diagnosis by a rater who is 
a trained research assistant. If there was discrepancy in symptom ratings and/or diagnosis, consensus 
was reached through the aid of a PhD level clinician (M.B). The SCID-II has been shown both high 
reliability and validity (Spitzer, Williams, Gibbon, & First, 1989). Inter-rater reliability was  = .74.  
Measures of external correlates  
Perceived Stress Scale (PSS – Cohen & Williamson, 1988).  Both studies (substance users 
and undergraduate students) received the PSS, a 10-item scale taken from the original 14-item scale 
(Cohen, Kamarck, and Mermelstein, 1983). This scale is aimed at measuring self-report of stress in daily 
life over the last month. Items appear on a 4-point scale (0 = Never, 4 = Very often). Items include “In the 
last month, how often have you been upset because of something that happened unexpectedly.”  
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Appendix C. Continued 
This measure has demonstrated good validity (Cohen & Williamson, 1988; Cohen & Williamson, 1991) 
and short-term reliability (e.g. 4 – 8 weeks; Cohen, Kamarck, and Mermelstein, 1983). In both samples, 
substance users and undergraduate students, Cronbach’s α = 72 and α = .85 respectively. 
Positive and Negative Affect Scale (PANAS; Watson & Clark, 1988). Both studies (substance 
users and undergraduate students) completed the Positive and Negative Affect Schedule (PANAS). The 
PANAS assesses affective experiences over the past month, specifically positive feelings α = .84 (i.e. 
Enthusiastic) and negative feelings α = .84 (scared). Participants are asked to rate the extent to which 
they experienced each particular emotion on a five-point scale (1 = very slightly – 5 = very much) for 20 
items. This measure has been accurately discriminates between negative and positive affect (Watson 
1998; Chen, Dai, Spector, Jex, 1997; Joiner & Blalock, 1995) such that each scale (negative, positive) is 
considered an independent construct and exhibits high test-retest reliability (Crawford & Henry, 2004). In 
Study 1 (substance users) for the total scale, positive affect, and negative affect, Cronbach’s α =.85, .90, 
.90 respectively.  In Study 2 (undergraduate students) for the total scale, positive affect, and negative 
affect, Cronbach’s α = .82, .88, .83 respectively. 
UPPS-P Impulsive Behavior Scale (UPPS-P; Lynam et al.,  2006).  Both studies (substance 
users and undergraduate students) received the UPPS-P, a 59-item inventory that measures five 
subscales of impulsive behavior. The five subscales include Negative Urgency (i.e., “I have trouble 
controlling my impulses”), Positive Urgency (i.e., “When I am very happy, I can’t seem to stop myself from 
doing things that can have bad consequences.”) (lack of) Premeditation (i.e., ”I have a reserved an 
cautious attitude towards life”), (lack of) Perseverance (i.e., “I tend to give up easily”), and Sensation-
Seeking (i.e., “I'll try anything once). The subscales have 11, 13, 12, 10, and 14 items respectively, each 
of which are calculated by taking the mean of the items. The items have a 4-point Likert scale (1-strongly 
agree to 4-strongly disagree). This measure has demonstrated external validity with antisocial personality 
traits, pathological gambling, and borderline personality features (Whiteside, Lynam, Miller, & Reynolds, 
2005). In substance users: Negative Urgency: α = .80; (lack of) Premeditation: α = .83; (lack of) 
Perseverance: α = .74; Sensation-Seeking: α =.84; Positive Urgency: α = .91, total scale: α = .92.  
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Appendix C. Continued 
In undergraduate students: Negative Urgency: α = .86; (lack of) Premeditation: α = .86; (lack of) 
Perseverance: α = .80; Sensation-Seeking: α =.86; Positive Urgency: α = .92, total scale: α = .90. 
Externalizing Behaviors. EXT-159 (Venables & Patrick, 2012). Study 2 (substance users) 
received the EXT -159, a self-report measure of externalizing behaviors and traits. This measure is 
adapted from the 415-item version and 100-item version of the Externalizing Spectrum Inventory (ESI, 
Bernat, et al., 2011; Nelson, et al., 2011; Hall, Bernat & Patrick, 2007; Blonigen et al., 2011) and has 
been shown to represent all 23 subscales of the ESI. Items appear on a 4-point scale (1 = True, 4 = 
False). The scale has four subscales: disinhibition (DIS), callous-aggression (AGG), and substance 
abuse (SUB). Item examples for each of the three subscales include, “I get in trouble for not considering 
the consequences of my action (DIS);” “I’ve told lies about someone just to see how it would affect them 
(AGG),” “I’ve smoked marijuana at a party (SUB).” The EXT-159 has demonstrated good validity in 
previous study (Venable & Patrick, 2012). In substance users, total score was used, Cronbach’s α = .99.   
Distress Tolerance.  In both studies substance users and undergraduate students, received self-
report measures of distress tolerance at A1. For purposes of data reduction, I performed a principal 
components analysis and calculated a regression score for three self-report measure (loadings were 
>|.5|) in order to create a distress tolerance factor.   
Frustration Discomfort Scale (FDS; Harrington, 2005b). Both studies (substance users and 
undergraduate students) received self-report questionnaires of an individual’s tolerance to distress. It 
consists of 35 items, with four 7-item subscales: discomfort intolerance, entitlement, emotional 
intolerance, and achievement. Apart from two items, all statements were worded only in terms of 
frustration intolerance. Individuals were asked to rate the strength of belief on a 5-point Likert-type scale 
(1 – absent; 5 – very strong). This measure has demonstrated both good internal consistency (α ≥ .84; 
Harrington, 2005b; Harrington, 2005a) and discriminant validity.  Internal consistency of this measure is 
high in previous studies (α ≥ .84; Harrington, 2005b).  In both samples, substance users and 
undergraduate students, Cronbach’s α = .94 and .92 respectively.   
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Appendix C. Continued 
Distress Tolerance Scale- DTS (Simons & Gaher, 2005). Both studies (substance users and 
undergraduate students) received the self-report questionnaire of an individual’s tolerance to stress. It 
consists of 16 items reflecting four subscales: ability to tolerate emotional distress, appraisal of distress, 
absorbed by negative emotion, and regulation efforts to alleviate distress. Items are rated on a 5-point 
scale (1 – Strongly agree; 5 – Strongly disagree). Example items include, “I can’t handle feeling 
distressed or upset”. This measure has demonstrated both good reliability and validity (reliability: r = .61; 
internal consistency: α = .80; Simons & Gaher, 2005).  Previous studies have shown that these measure 
correlate with BPD, such that BPD individuals evidence lower tolerance to stress in comparison to normal 
population (Chapman, Gratz, & Brown, 2006; Gratz, Rosenthal, Tull, Lejuez, & Gunderson, 2006). This 
self-report measure has been shown to be reliable and valid measures of an individual’s tolerance to 
stress (Simons & Gaher, 2005). In both samples, substance users and undergraduate students, 
Cronbach’s α = .89 and .86 respectively. 
Tolerance of Negative Affective States Scale – (TNASS - Bernstein and Brantz, 2012). Both 
studies (substance users and undergraduate students) received this 25-item self-report questionnaire 
examining an individual’s tolerance of negative emotions.  Participants were asked to rate mood items, 
(e.g. “sad” or “angry”) and how tolerant they are of these emotions (1 = intolerant, 5 = very tolerant). 
Tolerance and intolerance are defined in the measure’s completion directions. This measure has shown 
good internal consistency α = .92 and has been related to other measures of distress tolerance while 
discriminating from other measures of pure negative affect (Bernstein & Brantz, 2012). In both samples, 
substance users and undergraduate students, Cronbach’s α = .96 and .93 respectively.  
Childhood abuse. Both studies (substance users and undergraduate student) received this self-report 
measure that assesses experiences with childhood abuse, the Childhood Trauma Questionnaire-Short 
Form (CTQ-SF; Bernstein et al., 2003). The CTQ-SF is a 28-item measure that assesses childhood 
maltreatment experiences (i.e., "while you were growing up") using a five-point scale ranging from 1 
(never true) to 5 (very often true) across physical, sexual, and emotional abuse, and physical and 
emotional neglect.  
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Appendix C. Continued 
Sample items include: “Someone tried to touch me in a sexual way, or tried to make me touch them,” 
“People in my family hit me so hard that it left me with bruises or marks,” and “People in my family called 
me things like ‘stupid,’ ‘lazy,’ or ‘ugly.’” The CTQ-SF has good sensitivity (.78 –.86) and satisfactory 
specificity (.61–.76) when self-reports are compared with trauma ratings from child welfare records and 
reports of family members and clinicians (Bernstein, et al., 2003). Similarly, among a sample of adult 
substance abusers, the CTQ demonstrated good test-retest reliability over a period of greater than 1 
month (r = .86, p < .01; see Bernstein & Fink, 1998). In the current studies I utilized the subscale of abuse 
(sexual, physical, and emotional abuse. In both samples, substance users and undergraduate students, 
Cronbach’s α = .89 and .91, respectively for the subscale of abuse.  
Antisocial Personality Disorder. Study 1 (substance users) received diagnostic interviews for 
conduct disorder and adult antisocial behavior based on the Structured Clinical Interview for DSM-IV Axis 
II Disorders (SCID-II ASPD) to determine both symptom count and diagnosis for both (First, et al., 1997). 
In order to measure reliability, 25% of the audio taped interviews will be rated independently for symptom 
count and diagnosis by two raters who will be trained research assistants. If there were discrepancies in 
symptom ratings and/or diagnosis, consensus will be reached with the aid of a PhD level psychologist 
(M.B). This measure has been shown both high reliability and validity (Spitzer, Williams, Gibbon, & First, 
1990). In Sample 1 (substance users) inter-rater reliability was CD ( = .96) and for AAB ( = .67).  
Axis I Psychopathology. Both studies (substance users and undergraduate students) received 
the Mini-International Neuropsychiatric Interview (M.I.N.I.; Sheehan et al., 1999), a short structured 
diagnostic interview for DSM-IV and ICD-10 disorders, including Major Depressive Disorder (MDD), 
Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), and Alcohol and 
Substance Abuse/Dependence and Panic Disorder (PD). Symptom counts were assessed. In order to 
measure reliability, 25% of the audio-taped interviews were rated independently for symptom count and 
diagnosis by two raters who are trained research assistants. If there were discrepancies in symptom 
ratings and/or diagnosis, consensus was through the aid of a PhD level clinician (M.B.). Kappas were as 
follows for each individual diagnosis.  
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Appendix C. Continued 
For undergraduate students: MDD (current  = .84, lifetime  = .79), PTSD ( = 1.00), PD ( = 1.00), 
GAD(  = .74), alcohol dependence (1.00), substance dependencies ( = 1.00). For substance users: 
MDD (current  = .94; lifetime  = 1.00), PD ( = .95), PTSD ( = 1.00), GAD  ( = .93), AD ( =1.00), 
substances dependencies (s range from .96 – 1.00). This interview has shown concordance with the 
Structure Clinical Interview for Axis I DSM-IV Disorders (SCID-I; Sheehan, Lecrubier, & Sheehan, 1998). 
First, descriptives were conducted for symptoms counts of each individual diagnoses, and those which 
exhibited unacceptable skew (>|2|) and kurtosis (>|7|), were log transformed in order to reflect a more 
normal distribution.  In substance users, and undergraduate students, the following variables were log 
transformed because they exhibited skew and kurtosis outside the acceptable range: MDD current 
symptoms: 2.24 and 3.79 respectively; PD past symptoms 3.58 and 12.60 respectively; PTSD 2.97 and 
8.78 respectively, current DD: 5.85 and 36.71.  In both studies the following variables were calculated 
according to the same procedure. A max count was taken across current and past MDD symptoms to 
create a variable that indexed symptoms of MDD ever experienced. A composite variable for anxiety was 
calculated by taking the mean z-score of symptoms for these three disorders (current GAD, current 
PTSD, and lifetime PD). A composite variable for current substance dependence was calculated by taking 
a max count of dependence symptoms across drug classifications. A max count for current alcohol 
dependence symptoms was calculated.  
 National College Health Risk Behavior Survey (NCHRBS; Center for Disease Control, 1995). Both 
studies (substance users and undergraduate students) received the NCHRBS, a 77-item questionnaire 
that assesses six areas of behavior that affect the morbidity and mortality of adolescents and young 
adults. The CDC (Center for Disease Control) revised the instrument in 1995 for a total of 96 questions. 
NCHRBS is the first national survey to measure health risk behaviors among undergraduate students in 
all six areas. The six areas of health behavior remained unchanged behaviors that contribute to 
unintentional and intentional injuries; tobacco use; alcohol and other drug use; sexual behaviors that 
contribute to unintended pregnancy and STDs; unhealthy dietary behaviors; and physical inactivity. A 
max count was performed for two areas of alcohol use and drug use in the past year.  
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